コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 specific lethal effects of adozelesin, a DNA-alkylating drug.
2 ajor role in MMR-dependent cell death by DNA alkylating drugs.
3 ons to isolated DNA by other carcinogens and alkylating drugs.
4 nizing radiation, ultraviolet radiation, and alkylating drugs.
5 y enhances the sensitivity of tumor cells to alkylating drugs.
6 ation of R-loop helicase inhibitors with DNA alkylating drugs.
7 d with the sensitivity toward venetoclax and alkylating drugs.
8 oduce DNA damage, mice were treated with the alkylating drug, 1,4-bis[N,N'-di(ethylene)-phosphamide]p
9 Gy [13.0] for women), and chemotherapy with alkylating drugs (26 [2%] of 1195 women, 0.9 [0.5-1.5];
11 g Rnf4 are hypersensitive to hyroxyurea, DNA alkylating drugs and DNA crosslinking agents, but this s
12 gammaglobulinemia, conventional therapy with alkylating drugs, and recently, purine analogs and mAb-a
13 to these updated consensus recommendations, alkylating drugs (bendamustine, cyclophosphamide) and pr
14 18 times more sensitive to Bizelesin, a DNA alkylating drug compared to WT parasites as reflected by
15 oietic stem-cell transplantation, cumulative alkylating drug dose, and an interaction between age at
17 ease in children and parental treatment with alkylating drugs or preconception radiation doses to the
18 ement of pro- and anti-apoptotic proteins in alkylating drug resistance of tumor cells, we utilized t
19 melanoma therapy with temozolomide and other alkylating drugs suggests a combination approach where c
20 contribute to resistance of melanomas to the alkylating drugs temozolomide, dacarbazine, and fotemust
22 MDS after current or previous treatment with alkylating drugs were selected for evaluation by chart r
23 system might be sensitive to treatment with alkylating drugs whose toxicity depends on repair of thi